Pharma Suppliers Appeal CMA Action Over UK Market Rig

Law360, London (May 29, 2020, 10:44 PM BST) -- A pharmaceutical company and a former pharma executive have appealed the fines imposed on them by the UK's antitrust regulator for allegedly rigging the drug market's supply of an antidepressant drug.

In Thursday filings, Lexon (UK) Ltd. and Amit Patel⁠ — the former director of pharmaceutical company Auden Mckenzie⁠ — said the Competition and Markets Authority erred in its decision to fine them over £1 million each for allegedly taking part in a scheme that tried to keep prices of nortriptyline tablets high between 2014 and 2015, and from 2015 to 2017.

The fines were announced in March after a September...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!